International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels: International Diabetes Federation; 2021.
Google Scholar
Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017;389(10085):2239–51.
Article
CAS
PubMed
Google Scholar
Tuttolomondo A, Petta S, Casuccio A, Maida C, Corte VD, Daidone M, et al. Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study. Cardiovasc Diabetol. 2018;17(1):28.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tuttolomondo A, Cirrincione A, Casuccio A, Del Cuore A, Daidone M, Di Chiara T, Di Raimondo D, Corte VD, Maida C, Simonetta I, et al. Efficacy of dulaglutide on vascular health indexes in subjects with type 2 diabetes: a randomized trial. Cardiovasc Diabetol. 2021;20(1):1.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kaur R, Kaur M, Singh J. Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies. Cardiovasc Diabetol. 2018;17(1):121.
Article
CAS
PubMed
PubMed Central
Google Scholar
Okon EB, Chung AW, Rauniyar P, Padilla E, Tejerina T, McManus BM, et al. Compromised arterial function in human type 2 diabetic patients. Diabetes. 2005;54(8):2415–23.
Article
CAS
PubMed
Google Scholar
Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet. 1992;339(8793):572–5.
Article
CAS
PubMed
Google Scholar
Zhang H, Xiang S, Dai Z, Fan Y. Asymmetric dimethylarginine level as biomarkers of cardiovascular or all-cause mortality in patients with chronic kidney disease: a meta-analysis. Biomarkers. 2021;26(7):579–85.
Article
CAS
PubMed
Google Scholar
Ye J, Dai Y, Mao H, Zheng W, Zhang J. Prognostic value of asymmetric dimethylarginine in patients with coronary artery disease: a meta-analysis. Nitric Oxide. 2021;109–110:50–6.
Article
CAS
PubMed
Google Scholar
Murphy RB, Tommasi S, Lewis BC, Mangoni AA. Inhibitors of the hydrolytic enzyme Dimethylarginine Dimethylaminohydrolase (DDAH): Discovery, synthesis and development. Molecules. 2016;21(5):615.
Article
PubMed
PubMed Central
Google Scholar
Valkonen VP, Tuomainen TP, Laaksonen R. DDAH gene and cardiovascular risk. Vasc Med. 2005;10(Suppl 1):45–8.
Article
Google Scholar
di Masi A, De Simone G, Ciaccio C, D’Orso S, Coletta M, Ascenzi P. Haptoglobin: from hemoglobin scavenging to human health. Mol Aspects Med. 2020;73:100851.
Article
PubMed
Google Scholar
Etzerodt A, Moestrup SK. CD163 and inflammation: biological, diagnostic, and therapeutic aspects. Antioxid Redox Signal. 2013;18(17):2352–63.
Article
CAS
PubMed
PubMed Central
Google Scholar
Levy AP, Asleh R, Blum S, Levy NS, Miller-Lotan R, Kalet-Litman S, et al. Haptoglobin: basic and clinical aspects. Antioxid Redox Signal. 2010;12(2):293–304.
Article
CAS
PubMed
Google Scholar
Somer S, Levy AP. The role of haptoglobin polymorphism in cardiovascular disease in the setting of diabetes. Int J Mol Sci. 2020;22(1):287.
Article
PubMed
PubMed Central
Google Scholar
Wang S, Wang J, Zhang R, Wang T, Yan D, He Z, et al. Mendelian randomization analysis to assess a causal effect of haptoglobin on macroangiopathy in chinese type 2 diabetes patients. Cardiovasc Diabetol. 2018;17(1):14.
Article
CAS
PubMed
PubMed Central
Google Scholar
Leiper J, Murray-Rust J, McDonald N, Vallance P. S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase. Proc Natl Acad Sci U S A. 2002;99(21):13527–32.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sydow K, Munzel T. ADMA and oxidative stress. Atheroscler Suppl. 2003;4(4):41–51.
Article
CAS
PubMed
Google Scholar
Wang S, Wang J, Zhang R, Zhao A, Zheng X, Yan D, et al. Association between serum haptoglobin and carotid arterial functions: usefulness of a targeted metabolomics approach. Cardiovasc Diabetol. 2019;18(1):8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Soejima M, Koda Y. TaqMan-based real-time PCR for genotyping common polymorphisms of haptoglobin (HP1 and HP2). Clin Chem. 2008;54(11):1908–13.
Article
CAS
PubMed
Google Scholar
Li MF, Zhao CC, Li TT, Tu YF, Lu JX, Zhang R, et al. The coexistence of carotid and lower extremity atherosclerosis further increases cardio-cerebrovascular risk in type 2 diabetes. Cardiovasc Diabetol. 2016;15:43.
Article
PubMed
PubMed Central
Google Scholar
Rodriguez S, Gaunt TR, Day IN. Hardy-Weinberg equilibrium testing of biological ascertainment for mendelian randomization studies. Am J Epidemiol. 2009;169(4):505–14.
Article
PubMed
PubMed Central
Google Scholar
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559–75.
Article
CAS
PubMed
PubMed Central
Google Scholar
Carew AS, Levy AP, Ginsberg HN, Coca S, Lache O, Ransom T, et al. Haptoglobin phenotype modifies the influence of Intensive Glycemic Control on Cardiovascular Outcomes. J Am Coll Cardiol. 2020;75(5):512–21.
Article
CAS
PubMed
Google Scholar
Cahill LE, Levy AP, Chiuve SE, Jensen MK, Wang H, Shara NM, Blum S, Howard BV, Pai JK, Mukamal KJ, et al. Haptoglobin genotype is a consistent marker of coronary heart disease risk among individuals with elevated glycosylated hemoglobin. J Am Coll Cardiol. 2013;61(7):728–37.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cziraki A, Lenkey Z, Sulyok E, Szokodi I, Koller A. L-Arginine-nitric oxide-asymmetric dimethylarginine pathway and the coronary circulation: translation of Basic Science results to clinical practice. Front Pharmacol. 2020;11:569914.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tain YL, Hsu CN. Oxidative stress-induced hypertension of developmental origins: preventive aspects of antioxidant therapy. Antioxid (Basel). 2022;11(3):511.
Article
CAS
Google Scholar
Lin KY, Ito A, Asagami T, Tsao PS, Adimoolam S, Kimoto M, et al. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation. 2002;106(8):987–92.
Article
CAS
PubMed
Google Scholar
Dalan R, Liuh Ling G. The protean role of haptoglobin and haptoglobin genotypes on vascular complications in diabetes mellitus. Eur J Prev Cardiol. 2018;25(14):1502–19.
Article
PubMed
Google Scholar
Gurung RL, Yiamunaa M, Liu S, Liu JJ, Chan C, Choo RWM, et al. Association of haptoglobin phenotype with incident acute myocardial infarction in chinese patients with type 2 diabetes. Cardiovasc Diabetol. 2019;18(1):65.
Article
PubMed
PubMed Central
Google Scholar
Dowsett L, Higgins E, Alanazi S, Alshuwayer NA, Leiper FC, Leiper J. ADMA: a key player in the relationship between vascular dysfunction and inflammation in atherosclerosis. J Clin Med. 2020;9(9):3026.
Article
CAS
PubMed
PubMed Central
Google Scholar
Li T, Feng R, Zhao C, Wang Y, Wang J, Liu S, et al. Dimethylarginine Dimethylaminohydrolase 1 protects against High-Fat Diet-Induced hepatic steatosis and insulin resistance in mice. Antioxid Redox Signal. 2017;26(11):598–609.
Article
CAS
PubMed
Google Scholar
Palm F, Onozato ML, Luo Z, Wilcox CS. Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems. Am J Physiol Heart Circ Physiol. 2007;293(6):H3227-45.
Article
PubMed
Google Scholar
Hu X, Atzler D, Xu X, Zhang P, Guo H, Lu Z, et al. Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine. Arterioscler Thromb Vasc Biol. 2011;31(7):1540–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pope AJ, Karuppiah K, Cardounel AJ. Role of the PRMT-DDAH-ADMA axis in the regulation of endothelial nitric oxide production. Pharmacol Res. 2009;60(6):461–5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Caplin B, Nitsch D, Gill H, Hoefield R, Blackwell S, MacKenzie D, et al. Circulating methylarginine levels and the decline in renal function in patients with chronic kidney disease are modulated by DDAH1 polymorphisms. Kidney Int. 2010;77(5):459–67.
Article
CAS
PubMed
Google Scholar
Lind L, Ingelsson E, Kumar J, Syvanen AC, Axelsson T, Teerlink T. Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilation. Vasc Med. 2013;18(4):192–9.
Article
PubMed
Google Scholar
Lu TM, Lin SJ, Lin MW, Hsu CP, Chung MY. The association of dimethylarginine dimethylaminohydrolase 1 gene polymorphism with type 2 diabetes: a cohort study. Cardiovasc Diabetol. 2011;10:16.
Article
CAS
PubMed
PubMed Central
Google Scholar